Services - CRO/CMO/CDMO

InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands...

German mittelstand investor, Rantum Capital, through its Private Equity Fund II, has acquired Tontarra Medizintechnik, a leading German developer and manufacturer of high-precision, premium...

Prescient Healthcare Group, a UK-based product strategy consultancy to the global biopharmaceutical industry, has acquired London-based pricing and market access consultancy Dolon, strengthening its ability...

MTIP, a Switzerland-based specialist growth and buyout investor focused on European healthcare technology, has made a strategic investment in Verifarma, a Spain-headquartered provider of...

ProductLife Group (PLG), a European provider of outsourced development, regulatory and compliance services to the global life sciences industry, has appointed Dr James Burt...

An investor group led by Apollo is acquiring a 37% minority stake in Syntegon from CVC, marking the starting point for the firm’s next...

Germany-based CDMO, 1Q Health Group, has acquired EHF Production, a contract manufacturer based in the Netherlands. EHF Production has been developing and manufacturing supplements for...

UK-based life sciences marketing agency, ramarketing, has acquired US-based ISR Market Research, a specialist provider of primary research for the pharmaceutical outsourcing sector, including...

Switzerland-listed Lonza has agreed to sell its Capsules & Health Ingredients (CHI) business to UK-based Lone Star Funds for an enterprise value of CHF2.3bn...

Authors Dr Lakshiv Dhingra, Dr Seren Marsh, Abhishek Patel and Dr Victor Chua of Mansfield Advisors consider how the GLP-1 landscape will evolve over...